Blue Horseshoe Stocks: Friday’s Big Movers & More

LifeLogger Technologies Corp. LOGG

LOGG ended the week on an extremely high note, which was particularly impressive considering the fact that we had already witnessed a fantastic 91% pop from .0995-.19 subsequent to our mention of it in Thursday’s morning report.

The stock would follow up one great performance with another, running from an early low of .17 to a new high of .30 on Friday morning. It represented an intraday run of 76%, and a two-day overall rise amounting to 202% Our heartiest congratulations to any of our readers who were along for the ride on this one!

We’ll be sure to keep tracking LOGG for as long as its activity continues to provide these excellent intraday chances.

Encompass Compliance Corp. ENCC

ENCC turned out to be our top-gaining prospect of the day on Friday  when all was said and done. After slowly ramping up from its low of .012 over the course of the morning, the stock suddenly took off in the last hour, streaking to a high of .025.

The move amounted to an intraday increase of 108% and ENCC closed at its high point as well, so we’ll definitely want to assume our standard position for instances such as these, monitoring the stock for continued momentum, in addition to dip-and-rip patterns that could lead to further opportunities down the road.

PCS Edventures!.com, Inc. PCSV

On Friday, we classed PCSV as a stock to watch over the longer-term, and while that’s still the case, it also produced immediate results of an impressive nature.

We witnessed the stock trading in a range from .025-.045, which amounted to a respectable 80% intraday move.  As previously stated, we feel the company’s recent entry into the fledgling sport of competitive drone racing warrants extended observation of this stock. (>>View PR)

PositiveID Corp. PSID – Update

We want to touch upon PSID this morning with an update in the form of a video chart presentation, as well as a reminder that the company will be presenting its wares at SeeThruEquities’ 2nd Annual Innovations Investor Conference today in Miami, FL.

We’d also encourage any of our readers who may as yet be unfamiliar with PSID to visit our blog archive on the company and peruse recent posts. (>>PSID Archive)

DELRAY BEACH, Fla., Feb. 16, 2016 (GLOBE NEWSWIRE) — PositiveID Corporation (“PositiveID” or “Company”) (PSID), a life sciences company focused on detection and diagnostics, announced today that its Chairman and CEO, William J. Caragol, will present at the SeeThruEquity Second Annual in Miami, FL, on Monday, February 22, 2016, at the Ritz Carlton on South Beach.

Mr. Caragol will provide an update on PositiveID’s Firefly Dx real-time pathogen detection system, as well as an overview of the Company’s recent acquisitions of Thermomedics, which markets the FDA-cleared, non-contact Caregiver® thermometer, and E-N-G Mobile Systems, Inc. (“ENG”), a leader in mobile labs, homeland security and communications vehicles. (>>FULL PR)

Extended Watchlist:

Blue Horseshoe Stocks: PSID Update, SCTY Recap & More

PositiveID Corp. PSID

Our first order of business this morning is to go back and highlight the significant news from PSID yesterday concerning one of its recently acquired subsidiaries. Our regular readers will certainly recall from our initial report on PositiveID, that the company had completed the acquisition of Thermomedics and its  FDA-cleared Caregiver® non-contact infrared thermometer back in December (>>View PR).

Yesterday it was announced that five new healthcare product distribution firms had been added to its client roster for the Caregiver thermometer. We believe the reason the product has been able to catch on so quickly is largely due to the potential savings it offers healthcare facilities over more traditional thermometer technology. Thermometer covers cost money, and expend resources in their storage and disposal. The Caregiver, being totally non-contact, eliminates the need for covers along with their associated costs.

According to the company, the new agreements will effect “sequential monthly sales growth” and open up “near-term pipeline opportunities” for Thermomedics, which was already producing notable revenue prior to the announcement. This also represents excellent progress in terms of  PSID’s plans for growth in 2016.

SolarCity Corp. SCTY – Options Recap

With so much else to talk about yesterday morning, we had to hold off on congratulating any of our subscribers who caught our red-hot options idea for SCTY Weekly $19-17 Puts in Wednesday morning’s report.

We called for “potential intraday/intraweek swing-trade chances” in those contracts, and as is often the case when we set our sights upon a range of options ideas, every single strike point yielded ridiculously huge gain opportunities. The ranges provided represent Wednesday’s observed lows to yesterday’s closes at the highs-of-day.

$19 Puts – Trading Range: .26-2.35 – Max Gain: 804%
$18 Puts – Trading Range: .16-1.79 – Max Gain: 1018%
$17 Puts – Trading Range:  .06-1.11 – Max Gain: 1750%

Although it was an astonishingly good two-day play, SCTY is rebounding in the premarket today so it’s time to move on from this particular idea. Still, cheers to anyone who got in on the fun while it lasted! 

Extended Watchlist:

Blue Horseshoe Stocks: Momentum Play, Options & More

Shark Reach, Inc. SHRK

We’re going to be tagging SHRK for observation as a momentum mover this morning after noticing the huge activity in the stock yesterday. It came in conjunction with an article that Forbes ran about the company and its “influencer marketing” strategies. (>>View Article).

Many of our readers will have been aware of the marketing campaign that accompanied the theatrical release of the movie Straight Outta Compton, which was orchestrated by SharkReach. They promised Universal Pictures 7 million impressions and delivered more than 130 million, thanks in large part to the graphical memes that gained viral popularity for a period of months leading up to and following the film’s debut.

The rapid growth into a major player in less than three years of business definitely puts the company on our radar long term, but for the time being, there may be some short-term advantage to press with SHRK. We’ll look for profit-takers to surface after the stock’s rapid and meteoric rise, and be ready for a classic dip-and-rip scenario.

Facebook, Inc. FB – Options Ideas

With regard to a fresh options trading idea, we’re going to be watching Facebook for a possible move to the short side. The stock recently made a run that proved unsustainable, and the chart is looking rather toppy at the moment with a significant gap to fill to the low side.

For potential daytrading and intraweek swing-trade ideas we will be monitoring the Feb 5th $113-110 Puts. For a longer-term idea, assuming more hardship lay ahead for the stock, we’ll want to keep an eye on Feb 19th $109-105 Puts.

Extended Watchlist:

Blue Horseshoe Stocks: PSID Update, Options Recap & More

PositiveID Corp. PSID

We want to look at PSID from another angle this morning as we’re noticing a situation cropping up in international media that has the potential to affect the stock and its perceived value greatly.

For the better part of four months now, there has been a rising biological threat occurring in our own hemisphere. The Zika Virus is native to sub-Saharan Africa but is currently spreading across North, Central and South America at an alarming rate, according to the World Health Organization (WHO).

Some estimates have pinned the number of potential cases as high as four million, and thus far there have been reported cases in 21 countries from Mexica to the Caribbean to Brazil, where it appears to be the greatest threat at the moment (>>View Article)

. There is no cure, no treatment, and the disease is currently thought to spread exclusively via one particular species of mosquito. The ability to detect the virus quickly and without the need for brick-and-mortar lab testing could obviously be a useful tool in eventually bringing it and its effects under control, which are admittedly terrifying. Enter PositiveID and the Firefly Dx. We witnessed a monumental run from PSID back in 2014 when the Ebola scare reached global proportions (>>View Article) and we could be seeing the beginnings of a new scare with Zika.

While Zika is a relatively mild affliction by comparison, it’s one of its main side effects that is the reason for such concern. The infected person doesn’t feel much more than flu-like symptoms, and it clears itself up without treatment in a matter of days or weeks. However, the virus has been linked to a particularly horrific birth defect known as microcephaly, wherein pregnant women are contracting the virus and subsequently giving birth to infants with malformed skulls due to lack of cerebral development. Since October, there have been at roughly 4000 reported cases in Brazil alone. The link between the virus and microcephaly isn’t yet fully understood, adding to the potential for panic.

The Zika Virus story is now making headlines worldwide, and is likely to soon become a “household name” as experts are preparing for the possibility of an actual pandemic. Given that PSID’s Firefly Dx is rapidly approaching completed development, and the fact that once released it would be the only such device that could be configured to detect Zika in a matter of minutes instead of hours, it could offer medical professionals a real edge in combating this growing health emergency.

Stay tuned for future updates on PSID. If you didn’t catch Monday’s PSID Report  we suggest checking that out now.

Options Updates

We also want to congratulate any of our subscribers who caught our excellent options ideas in yesterday’s premarket report. We’ve been striking gold on the options front all week long, and yesterday served to continue that trend.

Facebook, Inc. FB – Our idea to track FB Weekly $105-110 Calls worked out incredibly well. Regardless of which of the six strike points was chosen, enormous single-session profits were there for the taking as FB stock itself traded up from the $104 to the $110-range.

$105 Calls – Trading Range: 1.07-5.45  – Max Gain: 409%
$106 Calls – Trading Range: .78-4.55 – Max Gain: 483%
$107 Calls – Trading Range: .47-3.61 – Max Gain: 668%
$108 Calls – Trading Range: .27-2.79  – Max Gain: 933%
$109 Calls – Trading Range: .15-2.13 – Max Gain: 1320%
$110 Calls – Trading Range: .07-1.40 – Max Gain: 1900%


Under Armour, Inc. UA - Our UA ideas were good as well, though they didn’t trade with quite the same liquidity and intensity as the FB options. Still, each of our monitored contracts in the range of UA Weekly $75-79.50 Calls did make appreciable intraday swings to the upside ranging from 118% ($75′s from 4.30-9.36) to 1700% in the case of the $79.50 Calls which ran from .25 to 4.62.

Extended Watchlist:

Blue Horseshoe Stocks: A Special Report

PositiveID Corp. PSID

As a special point of focus today, we’re going to be talking about PSID, and the reasons for our attraction to this stock are numerous. From fundamentals to technicals, PSID has the look of a high potential play, so this morning we’ll outline what we feel are some of the highlights to provide our readers with a good jumping-off point from which to start their own due diligence.  


One of the first things that strikes us with regard to PSID is the frequency and substance of recent press releases. The company appears to be taking a proactive and multifaceted approach to its growth including two complementary acquisitions, as well as the announcement of other updates regarding its existing technologies (pictured below).

Prior to the end of 2015, PSID‘s two primary products under development were the Firefly Dx handheld point-of-need diagnostic device, and the M-BAND bio-threat detector.

The M-BAND is serious business, detecting potentially harmful biological agents in high-traffic public locales such as airports and subway terminals. It was developed with funds attained via the Department of Homeland Securities next-gen BioWatch program, and PSID has an exclusive licensing and manufacturing agreement with the Boeing Company.

The company’s working prototype Firefly Dx has proven successful at detecting influenza, MRSA, E.coli, and several other harmful pathogens without the help of a brick-and-mortar lab, and according to the company’s projections a fully field-testable unit will be functional later this year. When perfected, it will provide a highly synergistic complement to PSID’s other recent acquisitions.

The first of which was in the beginning of December, when the company acquired Thermomedics, Inc. and its flagship product, the FDA-cleared Caregiver® non-contact infrared thermometer. (>>View PR)

Just prior to the new year PSID announced another exciting acquisition that has the ability to take its business to the next level, as it ties the company’s other technologies together. E-N-G Mobile Systems has been in business for 25 years, and has averaged $4M in revenue annually with its mobile laboratories. With the added facility of ambulatory lab systems, PositiveID’s ability and effectiveness in addressing the ever-growing necessity for rapid biological threat detection in the field should be stronger than ever. (>>View PR)

In addition to the expansion of its portfolio, PSID has also been making fundamental strides, as recent filings clearly indicate. The 2015 fiscal year brought increased revenues and cash flow, and the recent acquisitions should serve to bolster those figures even further in 2016. (>>View Filings)

We also want to look at the PSID chart, which in and of itself would be reason enough for us to track this stock. Over the past three consecutive sessions PSID has recorded higher highs and higher lows, building support off of its recently established 52-week low. This is exactly the type of ripening bounce-play setup that we search for on a daily basis.

As is evident on the snapshot below, the stock also has a documented history of making rapid moves to the upside. We could be catching this play at a prime moment for a continued recovery, so it will be among our top interests in sessions to come.




For More Information on PositiveID visit: